Bullish signal on daily chart

Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 776.90 |
| High | 788.00 |
| Low | 771.40 |
| Prev Close | 765.40 |
| Volume | 4,83,256 |
| VWAP(₹) | 782.29 |
| PE Ratio(x) | 130.14 |
| EPS - TTM(₹) | 6.03 |
| MCap(₹ Cr.) | 31,414.91 |
| MCap Rank | 7 |
| PB Ratio(x) | 11.94 |
| Div Yield(%) | - |
| Face Value(₹) | 2.00 |
| 52W High(₹) | 811.00 |
| 52W Low(₹) | 575.80 |
| MCap/Sales | 6.38 |
| Beta(1 Month) | - |
| BV/Share(₹) | 63.94 |
Board Meeting was held on Jun 13, 2026
Meeting Agenda: Others. Please add to watchlist to track closely.Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 28.16% outperformed its 3 year CAGR of 20.68%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 5.19% of its operating revenues towards interest expenses and 17.46% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)Krishna Instt of Medical Sciences Share Price Update
Krishna Institute of Medical Sciences Ltd. share price moved up by 2.58% from its previous close of Rs 765.40. Krishna Institute of Medical Sciences Ltd. stock last traded price is 785.10
| Share Price | Value |
|---|---|
| Today/Current/Last | 785.10 |
| Previous Day | 765.40 |
Found Insights useful?
| 1 Day | 2.58% |
| 1 Month | 4.67% |
| 3 Months | 18.17% |
| 1 Year | 18.72% |
| 3 Years | 143.8% |
| 5 Years | N.A. |
13 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 |
| Buy | 7 | 7 | 7 | 7 |
| Hold | 1 | 1 | 1 | 1 |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 13 | 13 | 13 | 13 |
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|
| Total Income | 1,002.90 | 964.90 | 878.70 | 801.40 | 790.20 |
| Total Income Growth (%) | 3.94 | 9.81 | 9.65 | 1.42 | 1.01 |
| Total Expenses | 877.50 | 823.10 | 732.40 | 640.70 | 629.90 |
| Total Expenses Growth (%) | 6.61 | 12.38 | 14.31 | 1.71 | 4.95 |
| EBIT | 125.40 | 141.80 | 146.30 | 160.70 | 160.30 |
| EBIT Growth (%) | -11.57 | -3.08 | -8.96 | 0.25 | -11.97 |
| Profit after Tax (PAT) | 53.40 | 66.90 | 78.60 | 101.80 | 88.70 |
| PAT Growth (%) | -20.18 | -14.89 | -22.79 | 14.77 | -17.41 |
| EBIT Margin (%) | 12.50 | 14.70 | 16.65 | 20.05 | 20.29 |
| Net Profit Margin (%) | 5.32 | 6.93 | 8.95 | 12.70 | 11.23 |
| Basic EPS (₹) | 1.33 | 1.67 | 1.96 | 2.54 | 2.22 |
All figures in Rs Cr, unless mentioned otherwise
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 28.16% outperformed its 3 year CAGR of 20.68%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 5.19% of its operating revenues towards interest expenses and 17.46% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)| Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Assets | 5,736.00 | 3,852.02 | 2,941.30 | 1,907.35 | 1,436.15 |
| Total Assets Growth (%) | 48.91 | 30.96 | 54.21 | 32.81 | 20.09 |
| Total Liabilities | 3,317.20 | 1,758.78 | 1,003.34 | 496.71 | 559.96 |
| Total Liabilities Growth (%) | 88.61 | 75.29 | 102.00 | -11.30 | -4.19 |
| Total Equity | 2,418.80 | 2,093.24 | 1,937.96 | 1,410.64 | 876.20 |
| Total Equity Growth (%) | 15.55 | 8.01 | 37.38 | 61.00 | 43.30 |
| Current Ratio (x) | 0.83 | 1.21 | 1.61 | 1.83 | 1.62 |
| Total Debt to Equity (x) | 0.89 | 0.57 | 0.32 | 0.12 | 0.33 |
| Contingent Liabilities | 1,347.30 | 555.71 | 458.97 | 103.57 | 42.37 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 581.80 | 521.09 | 432.09 | 324.03 | 355.97 |
| Net Cash used in Investing Activities | -1,116.20 | -752.56 | -615.60 | -411.52 | -354.18 |
| Net Cash flow from Financing Activities | 543.10 | 216.76 | 88.34 | 61.00 | 9.82 |
| Net Cash Flow | 9.10 | -14.72 | 35.98 | -26.50 | 11.62 |
| Closing Cash & Cash Equivalent | 56.00 | 46.89 | 61.61 | 25.63 | 52.13 |
| Closing Cash & Cash Equivalent Growth (%) | 19.43 | -23.89 | 140.35 | -50.83 | 28.67 |
| Total Debt/ CFO (x) | 3.28 | 2.01 | 1.23 | 0.50 | 0.80 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 1451.7 cr for investing activities which is an YoY increase of 30.06%. (Source: Consolidated Financials)| Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Return on Equity (%) | 17.98 | 16.96 | 20.14 | 23.98 | 23.29 |
| Return on Capital Employed (%) | 13.01 | 14.91 | 18.92 | 27.38 | 26.90 |
| Return on Assets (%) | 6.70 | 8.05 | 11.43 | 17.44 | 14.01 |
| Interest Coverage Ratio (x) | 9.02 | 13.90 | 20.62 | 33.43 | 11.73 |
| Asset Turnover Ratio (x) | 0.63 | 0.74 | 0.61 | 0.76 | 0.77 |
| Price to Earnings (x) | 66.67 | 53.19 | 33.56 | 33.22 | - |
| Price to Book (x) | 11.96 | 9.01 | 6.74 | 7.96 | - |
| EV/EBITDA (x) | 33.97 | 27.14 | 19.03 | 20.59 | - |
| EBITDA Margin (%) | 26.84 | 26.15 | 28.66 | 32.47 | 28.65 |
Found Financials useful?
5 Day EMA Crossover
Bullish signal on daily chart
Appeared on: 12 Jun 2026
5D EMA: 775.72
Average price gain of 2.82% within 7 days of Bullish signal in last 5 years
10 Day EMA Crossover
Bullish signal on daily chart
Appeared on: 12 Jun 2026
10D EMA: 771.61
Average price gain of 2.90% within 7 days of Bullish signal in last 5 years
Heikin-Ashi Changeover
Bullish indication on daily chart
Prev. Close Price
780.35
LTP
785.10
On daily price chart, Heikin-Ashi candle changed from Red to Green
14 Day EMA Crossover
Bullish signal on daily chart
Appeared on: 11 Jun 2026
14D EMA: 764.83
Average price gain of 2.84% within 7 days of Bullish signal in last 5 years
MACD Crossover
Bearish signal on daily chart
Appeared on: 10 Jun 2026
Region: Positive
Average price decline of -3.64% within 10 days of Bearish signal in last 10 years
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
| R1 | 791.60 | Pivot 781.50 | S1 | 775.00 |
| R2 | 798.10 | S2 | 764.90 | |
| R3 | 814.70 | S3 | 748.30 |
| 5 Days | 14 Days | 28 Days |
| 27.32 | 28.18 | 26.99 |
Found Technicals useful?
Choose from Peers
Choose from Stocks
MF Ownership as on 30 April 2026
821.64
Amount Invested (in Cr.)
2.21223266%
% of AUM
0.00
% Change (MoM basis)
742.27
Amount Invested (in Cr.)
1.94%
% of AUM
0.00
% Change (MoM basis)
675.42
Amount Invested (in Cr.)
2.4683%
% of AUM
0.00
% Change (MoM basis)
Board Meeting
Others
Jun 10, 2026
Board Meeting
Audited Results
May 06, 2026
General Meeting
-
Mar 16, 2026
| Announced on | Meeting on |
| Jun 10, 2026 | Jun 13, 2026 |
| Others | |
| May 06, 2026 | May 15, 2026 |
| Audited Results | |
| Mar 06, 2026 | Mar 11, 2026 |
| Rights Issue & Others | |
| Feb 02, 2026 | Feb 06, 2026 |
| Quarterly Results | |
| Oct 24, 2025 | Nov 07, 2025 |
| Quarterly Results | |
No Data Available
No Data Available
| Announced on | Ex-Date |
| Jun 28, 2024 | Sep 13, 2024 |
| Split: Old FV10.0| New FV:2.0 | |
No Data Available
| Announced on | Meeting on |
| Mar 16, 2026 | Apr 17, 2026 |
| - | |
| Jan 05, 2026 | Feb 03, 2026 |
| - | |
| Aug 08, 2025 | Aug 29, 2025 |
| - | |
| Feb 17, 2025 | Mar 18, 2025 |
| - | |
| Aug 07, 2024 | Aug 29, 2024 |
| - | |
Krishna Institute of Medical Sciences Ltd., incorporated in the year 1973, is a Small Cap company (having a market cap of Rs 31,414.91 Crore) operating in Hospitals & Allied Services sector.
Industry
Key Indices Listed On
Nifty 500, BSE 500, BSE 250 SmallCap Index, BSE SmallCap, BSE Healthcare
Address
D.No. 1-8-31/1,Minister Road,Secunderabad, Telangana - 500003
Bhaskara Rao Bollineni
Chairman & Managing DirectorAbhinay Bollineni
Executive Director & CEOAnitha Dandamudi
Whole Time DirectorAdwik Bollineni
Non Executive DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.